Skip to main content

NIH Accelerating Medicines Partnership has awarded 10 US centers grants to study Rheumatoid Arthritis and Lupus

test_associate_editor@test.com
Dec 02, 2014 3:44 pm

In September 2014, the participating members of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Program funded a research Network to implement the program. The Network comprises a Leadership Center and several research sites that will work collaboratively to define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of RA, lupus, and related autoimmune diseases.

×